Articles Referencing AF

Zacks.com

St. Jude's 1Q Earnings In Line - Analyst Blog

St. Jude Medical 's ( STJ ) first-quarter adjusted earnings per share of 92 cents were in line with the Zacks Consensus Estimate and transcended the year-ago earnings of 86 cents.... Read >>

Zacks.com

Encouraging Results on ISIS Drug - Analyst Blog

Isis Pharmaceuticals, Inc. ( ISIS ) recently announced encouraging results from a phase I study on its candidate, ISIS-CRP. In the study, ISIS-CRP demonstrated significant reduction of the... Read >>

Zacks.com

Milestone for St. Jude's ACP - Analyst Blog

St. Jude Medical Inc. ( STJ ) has reached yet another important clinical landmark by registering the first implant of its Amplatzer Cardiac Plug (ACP) in a clinical trial. The ACP clinical... Read >>

Zacks.com

Bayer/JNJ's Xarelto in New Studies - Analyst Blog

Bayer 's ( BAYRY ) Healthcare unit and its partner Johnson & Johnson ( JNJ ) recently initiated a phase III study (COMMANDER-HF) on Xarelto (rivaroxaban) in patients suffering... Read >>

Zacks.com

CE Mark for MDT's Performa Lead - Analyst Blog

Medical Device major - Medtronic ( MDT ) recently won European CE Mark approval for its portfolio of Attain Performa Quadripolar leads. Following the approval, European launch of the same... Read >>

Zacks.com

Pipeline Advances at Isis Pharma - Analyst Blog

Isis Pharmaceuticals, Inc. ( ISIS ) recently announced that it has initiated a phase II study (n = 20) to evaluate the safety and efficacy of its paroxysmal atrial fibrillation (AF)... Read >>

Zacks.com

Cardiome Selects Quintiles - Analyst Blog

Cardiome Pharma Corp. ( CRME ) recently selected privately-held Quintiles for providing lifecycle safety and global regulatory affairs services for Brinavess (vernakalant intravenous). The... Read >>

NASDAQ.com News

Astoria Financial Corporation (AF) Ex-Dividend Date Scheduled for February 13, 2013

Astoria Financial Corporation ( AF ) will begin trading ex-dividend on February 13, 2013. A cash dividend payment of $0.04 per share is scheduled to be paid on March 01, 2013. Shareholders who... Read >>

Zacks.com

St. Jude Beats Estimates - Analyst Blog

St. Jude Medical 's ( STJ ) fourth-quarter adjusted earnings per share of 92 cents topped the Zacks Consensus Estimate by 2 cents and transcended the year-ago earnings of 86 cents. The... Read >>

Zacks.com

CE Mark for St. Jude's Products - Analyst Blog

St. Jude Medical ( STJ ) has received CE Mark approval for two of its devices viz. the AMPLATZER Amulet Left Atrial Appendage Occluder and the ViewFlex Xtra Intracardiac Echocardiography... Read >>

Zacks.com

Medtronic Expands AF Product Line - Analyst Blog

Leading medical devices player, Medtronic ( MDT ) has strengthened its growing atrial fibrillation (AF) business. This is on account of the fact that  it has received the U.S. Food and... Read >>

Zacks.com

St. Jude Reports Prelim 4Q Results - Analyst Blog

Medical devices major, St. Jude Medical Inc. ( STJ ) released preliminary results for the 2012-fourth quarter. The company will report its financial results on Jan 23, before markets opens.... Read >>

NASDAQ.com News

After-Hours Earnings Report for July 18, 2012 : AXP, EBAY, CLB, CCK, EWBC, CVA, CNS, CVBF, AF, BPFH, EGHT, CVCY

The following companies are expected to report earnings after hours on 07/18/2012. Visit our Earnings Calendar for a full list of expected earnings releases. American Express Company ( AXP ... Read >>

Zacks.com

Priority FDA Review for Eliquis - Analyst Blog

Recently, Bristol-Myers Squibb Company ( BMY ) and Pfizer Inc . ( PFE ) announced that their anti-clotting drug Eliquis (apixaban) will be reviewed on a priority basis by the US... Read >>

Zacks.com

BostonRelies on Watchman - Analyst Blog

With its core segments of stents and defibrillators struggling, leading medical devices player Boston Scientific Corporation ( BSX ) is targeting other emerging therapies with high... Read >>

Displaying 1-15 of 17
<< first < previous 1 2 next > last >>